Cargando…
Cabergoline Treatment in Invasive Giant Prolactinoma
Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076446/ https://www.ncbi.nlm.nih.gov/pubmed/25002819 http://dx.doi.org/10.4137/CCRep.S15790 |
_version_ | 1782323485080551424 |
---|---|
author | Alsubaie, Sadeem Almalki, Mussa H |
author_facet | Alsubaie, Sadeem Almalki, Mussa H |
author_sort | Alsubaie, Sadeem |
collection | PubMed |
description | Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically. |
format | Online Article Text |
id | pubmed-4076446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-40764462014-07-07 Cabergoline Treatment in Invasive Giant Prolactinoma Alsubaie, Sadeem Almalki, Mussa H Clin Med Insights Case Rep Case Report Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically. Libertas Academica 2014-06-19 /pmc/articles/PMC4076446/ /pubmed/25002819 http://dx.doi.org/10.4137/CCRep.S15790 Text en © 2014 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article published under the Creative Commons CC-BY-NC 3.0 License. |
spellingShingle | Case Report Alsubaie, Sadeem Almalki, Mussa H Cabergoline Treatment in Invasive Giant Prolactinoma |
title | Cabergoline Treatment in Invasive Giant Prolactinoma |
title_full | Cabergoline Treatment in Invasive Giant Prolactinoma |
title_fullStr | Cabergoline Treatment in Invasive Giant Prolactinoma |
title_full_unstemmed | Cabergoline Treatment in Invasive Giant Prolactinoma |
title_short | Cabergoline Treatment in Invasive Giant Prolactinoma |
title_sort | cabergoline treatment in invasive giant prolactinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076446/ https://www.ncbi.nlm.nih.gov/pubmed/25002819 http://dx.doi.org/10.4137/CCRep.S15790 |
work_keys_str_mv | AT alsubaiesadeem cabergolinetreatmentininvasivegiantprolactinoma AT almalkimussah cabergolinetreatmentininvasivegiantprolactinoma |